Metformin
(Diaformin, PMS-Metformin, Glycon, Diabex)
|
-
63 (31%) experienced major perceived effectiveness
-
73 (36%) experienced moderate perceived effectiveness
-
35 (17%) experienced slight perceived effectiveness
-
12 (6%) experienced no perceived effectiveness
-
|
-
35 (17%) experienced severe side effects
-
33 (16%) experienced moderate side effects
-
41 (20%) experienced mild side effects
-
93 (46%) experienced no side effects
|
202 |
|
|
-
19 (43%) experienced major perceived effectiveness
-
19 (43%) experienced moderate perceived effectiveness
-
3 (7%) experienced slight perceived effectiveness
-
2 (5%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
7 (16%) experienced moderate side effects
-
11 (25%) experienced mild side effects
-
26 (59%) experienced no side effects
|
44 |
|
|
-
8 (50%) experienced major perceived effectiveness
-
4 (25%) experienced moderate perceived effectiveness
-
2 (13%) experienced slight perceived effectiveness
-
1 (6%) experienced no perceived effectiveness
-
|
-
4 (25%) experienced severe side effects
-
4 (25%) experienced moderate side effects
-
4 (25%) experienced mild side effects
-
4 (25%) experienced no side effects
|
16 |
|
|
-
7 (54%) experienced major perceived effectiveness
-
3 (23%) experienced moderate perceived effectiveness
-
2 (15%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
1 (8%) experienced severe side effects
-
2 (15%) experienced moderate side effects
-
2 (15%) experienced mild side effects
-
8 (62%) experienced no side effects
|
13 |
Glipizide
(Glucotrol, Glipizide XL, Glipizide ER)
|
-
5 (45%) experienced major perceived effectiveness
-
3 (27%) experienced moderate perceived effectiveness
-
2 (18%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
1 (9%) experienced severe side effects
-
1 (9%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
9 (82%) experienced no side effects
|
11 |
|
|
-
4 (36%) experienced major perceived effectiveness
-
3 (27%) experienced moderate perceived effectiveness
-
2 (18%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
11 (100%) experienced no side effects
|
11 |
Glyburide
(Glynase PresTab, Glucovance, Euglukon)
|
-
4 (40%) experienced major perceived effectiveness
-
4 (40%) experienced moderate perceived effectiveness
-
1 (10%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
1 (10%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
3 (30%) experienced mild side effects
-
6 (60%) experienced no side effects
|
10 |
|
|
-
2 (20%) experienced major perceived effectiveness
-
6 (60%) experienced moderate perceived effectiveness
-
1 (10%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
1 (10%) experienced moderate side effects
-
5 (50%) experienced mild side effects
-
4 (40%) experienced no side effects
|
10 |
|
|
-
4 (44%) experienced major perceived effectiveness
-
4 (44%) experienced moderate perceived effectiveness
-
0 (0%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
2 (22%) experienced mild side effects
-
7 (78%) experienced no side effects
|
9 |
Insulin Aspart
(Novolog, NovoLog FlexPen, NovoRapid, NovoRapid Flexpen)
|
-
3 (43%) experienced major perceived effectiveness
-
2 (29%) experienced moderate perceived effectiveness
-
1 (14%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
1 (14%) experienced moderate side effects
-
3 (43%) experienced mild side effects
-
3 (43%) experienced no side effects
|
7 |
|
|
-
2 (29%) experienced major perceived effectiveness
-
2 (29%) experienced moderate perceived effectiveness
-
2 (29%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
2 (29%) experienced moderate side effects
-
1 (14%) experienced mild side effects
-
4 (57%) experienced no side effects
|
7 |
|
|
-
1 (17%) experienced major perceived effectiveness
-
3 (50%) experienced moderate perceived effectiveness
-
1 (17%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
1 (17%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
3 (50%) experienced mild side effects
-
2 (33%) experienced no side effects
|
6 |
|
|
-
1 (25%) experienced major perceived effectiveness
-
2 (50%) experienced moderate perceived effectiveness
-
1 (25%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
1 (25%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
1 (25%) experienced mild side effects
-
2 (50%) experienced no side effects
|
4 |